Studies on a new intramuscular haematinic, iron-sorbitol
- PMID: 14465561
- PMCID: PMC1482102
- DOI: 10.1111/j.1476-5381.1961.tb01122.x
Studies on a new intramuscular haematinic, iron-sorbitol
Abstract
A new iron preparation for intramuscular use is described. It contains a complex of iron, sorbitol and citric acid. Its properties in comparison with several other complexes, particularly iron-dextran, have been studied. The preparation is stable in serum, is hypertonic, does not produce haemolysis, and affects coagulation only at very high concentrations, such as are reached only in vitro. Absorption from muscle takes place very rapidly; two-thirds of the iron is removed within 3 hr, and there is a very rapid increase in the serum-iron concentration. In experimental animals, the maximum level is reached after about 20 min and in man after about 2 hr. Disappearance from the serum takes place rapidly. The preparation contains a small amount of a fraction which reacts with transferrin and is dialysable. In man, about 30% of the total dose of iron is excreted through the kidneys during the first 24 hr after injection, the greater part of the excretion taking place during the first few hours.
Similar articles
-
PARENTERAL IRON THERAPY. II. A NEW IRON-SORBITOL CITRIC ACID COMPLEX FOR INTRA-MUSCULAR INJECTION.Ann Intern Med. 1964 Dec;61:1053-64. doi: 10.7326/0003-4819-61-6-1053. Ann Intern Med. 1964. PMID: 14233826 No abstract available.
-
THE DISTRIBUTION OF PARENTERAL IRON HAEMATINICS IN NONPREGNANT, PREGNANT AND LACTATING RATS.Br J Pharmacol Chemother. 1964 Apr;22(2):275-88. doi: 10.1111/j.1476-5381.1964.tb02033.x. Br J Pharmacol Chemother. 1964. PMID: 14190463 Free PMC article.
-
Studies on an iron-poly(sorbitol-gluconic acid) complex for parenteral treatment of iron deficiency anaemia.Scand J Haematol Suppl. 1977;32:21-36. doi: 10.1111/j.1600-0609.1977.tb01211.x. Scand J Haematol Suppl. 1977. PMID: 272030
-
Treatment of iron deficiency.Clin Haematol. 1982 Jun;11(2):327-38. Clin Haematol. 1982. PMID: 7042154 Review. No abstract available.
-
Acute injury with intravenous iron and concerns regarding long-term safety.Clin J Am Soc Nephrol. 2006 Sep;1 Suppl 1:S19-23. doi: 10.2215/CJN.01420406. Clin J Am Soc Nephrol. 2006. PMID: 17699372 Review.
Cited by
-
[Physico-chemical studies on the ferritin and protein spectrum in a case of pulmonary hemosiderosis with glomerulonephritis. (Goodpasture's syndrome)].Klin Wochenschr. 1971 Dec 1;49(23):1257-64. doi: 10.1007/BF01733078. Klin Wochenschr. 1971. PMID: 5135944 German. No abstract available.
-
Experimental hepatic iron overload in the baboon: results of a two-year study. Evolution of biological and morphologic hepatic parameters of iron overload.Dig Dis Sci. 1983 Jul;28(7):616-24. doi: 10.1007/BF01299922. Dig Dis Sci. 1983. PMID: 6861591
-
Test of an iron sorbitol-citric acid complex (Jectofer) for carcinogenicity in rats.Br J Cancer. 1965 Dec;19(4):855-9. doi: 10.1038/bjc.1965.98. Br J Cancer. 1965. PMID: 5862662 Free PMC article. No abstract available.
-
Studies on sudden fatalities among piglets following parenteral iron therapy.Acta Vet Scand. 1972;13(2):206-17. doi: 10.1186/BF03548574. Acta Vet Scand. 1972. PMID: 4652523 Free PMC article.
-
In vivo behaviour of low molecular weight iron complexes.Eur J Drug Metab Pharmacokinet. 1991 Jul-Sep;16(3):203-6. doi: 10.1007/BF03189960. Eur J Drug Metab Pharmacokinet. 1991. PMID: 1814738
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources